País: Canadà
Idioma: francès
Font: Health Canada
Florfénicol; FLUNIXINE (MÉGLUMINE DE FLUNIXINE)
INTERVET CANADA CORP
300MG; 16.5MG
Solution
Florfénicol 300MG; FLUNIXINE (MÉGLUMINE DE FLUNIXINE) 16.5MG
Sous-cutanée
100ML/250ML/500ML
Prescription
Bétails
Numéro de groupe d'ingrédients actifs (GIA) :0252643001
APPROUVÉ
2009-07-30
Resflor product insert English February 14, 2023 1 DIN 02330997 Resflor ® Florfenicol/Flunixin, as flunixin meglumine FOR VETERINARY USE ONLY Injectable Solution Sterile Multi-dose Injectable Antibiotic/Non ‑ steroidal Anti ‑ inflammatory Solution For Subcutaneous Use in Cattle Only DESCRIPTION: Resflor is a sterile solution of a synthetic broad-spectrum antibiotic and a non ‑ steroidal anti ‑ inflammatory drug. Each milliliter of Resflor contains: ACTIVE INGREDIENTS: 300 mg florfenicol; 27.4 mg flunixin meglumine equivalent to 16.5 mg flunixin; NON ‑ MEDICINAL INGREDIENTS: 250 mg _N_ ‑ methyl ‑ 2 ‑ pyrrolidone (NMP), 10 mg citric acid and polyethylene glycol q.s.; PRESERVATIVE: 150 mg propylene glycol. INDICATIONS: Resflor is indicated for the treatment of bovine respiratory disease complex (BRD) associated with _Mannheimia haemolytica_, _Pasteurella _ _multocida _and _Histophilus somni _and BRD associated pyrexia. DOSAGE AND ADMINISTRATION: Resflor should be administered as a single subcutaneous dose of 40 mg/kg florfenicol and 2.2 mg/kg flunixin (2 mL/15 kg body weight or 6 mL/100 lbs body weight). Do not administer more than 10 mL at each injection site. THE INJECTION SHOULD BE GIVEN ONLY IN THE NECK. Do not puncture the stopper more than 20 times. RESFLOR DOSAGE GUIDE ANIMAL WEIGHT (KG) (LBS) RESFLOR DOSAGE 2 ML/15 KG BODY WEIGHT (ML) 45 100 6.0 90 200 12.0 135 300 18.0 180 400 24.0 225 500 30.0 270 600 36.0 315 700 42.0 360 800 48.0 405 900 54.0 450 1000 60.0 Resflor product insert English February 14, 2023 2 IT IS RECOMMENDED TO TREAT ANIMALS IN THE EARLY STAGES OF THE DISEASE AND TO EVALUATE THE RESPONSE TO TREATMENT 72 HOURS AFTER INJECTION. IF CLINICAL SIGNS OF RESPIRATORY DISEASE PERSIST OR INCREASE, OR IF RELAPSE OCCURS, TREATMENT SHOULD BE CHANGED, USING ANOTHER ANTIBIOTIC, AND CONTINUED UNTIL SIGNS HAVE RESOLVED. CONTRAINDICATIONS: Do not use in animals showing hypersensitivity to flunixin meglumine or florfenicol. CAUTIONS: Do not exceed the recommended dose. Transient inappetence Llegiu el document complet